| 1 |
33186562 | Bupropion monotherapy alters neurotrophic and inflammatory markers in patients of major depressive disorder. | 2021 Jan |
1 |
| 2 |
34218389 | Revisiting bupropion anti-inflammatory action: involvement of the TLR2/TLR4 and JAK2/STAT3. | 2021 Aug |
2 |
| 3 |
16644475 | A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. | 2006 Jun |
1 |
| 4 |
17009913 | Bupropion: pharmacology and therapeutic applications. | 2006 Sep |
1 |
| 5 |
17136226 | Bupropion. | 2006 Oct |
2 |
| 6 |
15533626 | Bupropion for fatigue and as a tumor necrosis factor-alpha lowering agent in primary biliary cirrhosis. | 2005 |
4 |
| 7 |
15922115 | Proposal for using small molecule tumor necrosis factor-alpha lowering agents, possibly bupropion, in aplastic anemia. | 2005 |
3 |
| 8 |
15928583 | Anti-apoptosis function of TNF-alpha in chronic lymphocytic leukemia: lessons from Crohn's disease and the therapeutic potential of bupropion to lower TNF-alpha. | 2005 Mar-Apr |
4 |
| 9 |
15964626 | Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities--the role of bupropion. | 2005 Dec |
1 |
| 10 |
15082113 | Combination of bupropion, paroxetine and quetiapine as adjuvant treatment for multiple myeloma. | 2004 |
2 |
| 11 |
12883127 | Bupropion in psoriasis and atopic dermatitis: decreased tumor necrosis factor-alpha? | 2003 Jul-Aug |
1 |